SAKATA-YANAGIMOTO Mamiko
- Articles
- MYD88 (L265P) MUTATION IS ASSOCIATED WITH AN UNFAVORABLE OUTCOME OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Hattori K.; Sakata-Yanagimoto M.; Okoshi Y.; Goshima Y.; Yana...
HAEMATOLOGICA/101(1)/pp.392-393, 2016-06 - RECOMBINANT THROMBOMODULIN AMELIORATES HEMATOLOGICAL MALIGNANCY-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION MORE PROMPTLY THAN CONVENTIONAL THERAPY WITHOUT CAUSING SEVERE HEMORRHAGIC EVENTS
Kurita N.; Yokoyama Y.; Muto H.; Kato T.; Sakata-Yanagimo...
HAEMATOLOGICA/101(1)/pp.310-310, 2016-06 - DOUBLE INACTIVATION OF TET2 AND TET3 INDUCES HYPOMETHYLATING AGENT-SENSITIVE ACUTE MYELOID LEUKEMIA
Maie K.; Sakata-Yanagimoto M.; Oshima M.; Kato T.; Muto H.; Mo...
HAEMATOLOGICA/101(1)/pp.212-212, 2016-06 - GENETIC LANDSCAPE OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Yoshida K.; Chiba K.; Okuno Y.; Kakiuchi N.; Suzuki S.; Suzuki...
HAEMATOLOGICA/101(1)/pp.179-179, 2016-06 - GENETIC PREDISPOSITIONS TO SPORADIC MYELOID NEOPLASMS CAUSED BY GERMLINE DDX41 MUTATIONS IN ASIAN AND CAUCASIAN POPULATIONS.
Takeda J.; Yoshida K.; Makishima H.; Yoshizato T.; Shiozawa Y...
HAEMATOLOGICA/101(1)/pp.66-67, 2016-06 - Complete Remission in Systemic Skin Interdigitating Dendritic Cell Sarcoma after ABVD Chemotherapy.
Kyogoku C; Seki M; Miyamoto K; Ito Y; Kurita N; Yokoyama ...
Journal of clinical and experimental hematopathology : JCEH/55(1)/pp.33-37, 2015-01 - Double somatic mosaic mutations in TET2 and DNMT3A origin of peripheral T cell lymphoma in a case.
Tran B. Nguyen; Mamiko Sakata-Yanagimoto; Rie Nakamoto-M...
Annals of Hematolgy/94(7)/pp.1221-1223, 2015-07 - Double somatic mosaic mutations in TET2 and DNMT3A origin of peripheral T cell lymphoma in a case.
Tran B. Nguyen; Mamiko Sakata-Yanagimoto; Rie Nakamoto-Mats...
ANNALS OF HEMATOLOGY/94(7)/pp.1221-1223, 2015-7 - Variegated RHOA mutations in adult T-cell leukemia/lymphoma.
Nagata Y; Kontani K; Enami T; Kataoka K; Ishii R; Totoki ...
BLOOD/127(5)/pp.596-604, 2016-02 - Improvement of Renal Function by Long-Term Sustained Eculizumab Treatment in a Patient with Paroxysmal Nocturnal Hemoglobinuria.
Ninomiya H; Obara N; Niiori-Onishi A; Yokoyama Y; Sakata-Yana...
Case Rep Hematol/2015/p.673195, 2015-06 - G17V RHOA: Genetic evidence of GTP-unbound RHOA playing a role in tumorigenesis in T cells.
Chiba Shigeru; Enami T; Ogawa S; Sakata-Yanagimoto M
Small GTPases/6(2)/pp.100-103, 2015-06 - Identification of a fusion gene composed of a Hippo pathway gene MST2 and a common translocation partner ETV6 in a recurrent translocation t(8;12)(q22;p13) in acute myeloid leukemia.
Ogawa S; Yokoyama Y; Suzukawa K; Nanmoku T; Kurita N; Seki M; M...
Ann Hematol/94(8)/pp.1431-1433, 2015-08 - CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis
Yoshida Noriaki; Miyoshi Hiroaki; Kato Takeharu; Sakat...
JOURNAL OF PATHOLOGY/238(5)/pp.621-626, 2016-04 - A nationwide survey of co-occurrence of malignant lymphomas and myelodysplastic syndromes/myeloproliferative neoplasms
Sakata-Yanagimoto Mamiko; Yokoyama Yasuhisa; Muto Hideha...
ANNALS OF HEMATOLOGY/95(5)/pp.829-830, 2016-04 - G17V Rhoa Mutation in Circulating DNA Is a Useful Marker for Diagnosis of AITL and AITL-Related Lymphoma
Nakamoto-Matsubara Rie; Sakata-Yanagimoto Mamiko; Tran Nguy...
BLOOD/126(23), 2015-12 - Genetic Basis of Primary Central Nervous System Lymphoma
Yoshida Kenichi; Nakamoto-Matsubara Rie; Chiba Kenichi...
BLOOD/126(23), 2015-12 - Genetic Predispositions to Myeloid Neoplasms Caused By Germline DDX41 Mutations
Takeda June; Yoshida Kenichi; Makishima Hideki; Yoshiz...
BLOOD/126(23), 2015-12 - Molecular Pathogenesis of Peripheral T Cell Lymphoma
Sakata-Yanagimoto Mamiko; Chiba Shigeru
CURRENT HEMATOLOGIC MALIGNANCY REPORTS/10(4)/pp.429-437, 2015-12 - Late occurrence of Epstein-Barr virus-associated lymphoproliferative disorder in a patient with follicular lymphoma treated with bendamustine and rituximab
Muroi Kei; Sakata-Yanagimoto Mamiko; Sato Taiki; Yokoyama Ya...
ANNALS OF HEMATOLOGY/94(12)/pp.2061-2062, 2015-12 - HEMATOLOGICAL RECOVERY AFTER INTRA-BONE MARROW CORD-BLOOD TRANSPLANT WAS ENHANCED THROUGH LOCAL ENGRAFTMENT OF INJECTED SITE. A SINGLE CENTER PROSPECTIVE PHASE I/II TRIAL IN JAPAN
Kurita N.; Yokoyama Y.; Suzuki S.; Seki M.; Sakata-Yanagimoto...
HAEMATOLOGICA/100(1)/pp.611-612, 2015-06 - ABNORMALITIES IN NESTIN-EXPRESSING BONE MARROW STROMAL CELLS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
Obara Naoshi; Chiba Shigeru; Kato Takayasu; Sakamoto Tatsuhi...
EXPERIMENTAL HEMATOLOGY/43(9::1)/pp.S86-S86, 2015-09 - TET2 as a gatekeeper for hematologic malignancies
武藤 秀治; 坂田（柳元） 麻実子; 千葉 滋
Rinsho Ketsueki/56(6)/pp.651-656, 2015 - Mutations in epigenetic and metabolic regulators in peripheral T-cell lymphoma
坂田（柳元） 麻実子
Rinsho Ketsueki/56(8)/pp.1053-1058, 2015-08 - Identification of a fusion gene composed of a Hippo pathway gene MST2 and a common translocation partner ETV6 in a recurrent translocation t(8;12)(q22;p13) in acute myeloid leukemia
Ogawa Shinichi; Yokoyama Yasuhisa; Suzukawa Kazumi; Na...
ANNALS OF HEMATOLOGY/94(8)/pp.1431-1433, 2015-08 - 血管免疫芽球性Tリンパ腫発症の分子メカニズム
坂田（柳元） 麻実子
臨床血液/56(3)/pp.246-252, 2015-03 - more...
- MYD88 (L265P) MUTATION IS ASSOCIATED WITH AN UNFAVORABLE OUTCOME OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA